Compliance Insight Blog

FDA has approved the first antiviral treatment for COVID-19

Dexamethasone Sodium Phosphate Added to the Lists of Drugs for Temporary Compounding by Outsourcing

FDA issues new temporary policy regarding state license pharmacies

FDA Continues to Accelerate Development of Novel Therapies for COVID-19

FDA Issues Seven Warning Letters to Companies Claiming to Treat or Prevent COVID-19

Compliance Insight announces Virtual Quality Assurance solution to provide competitive advantage

FDA Issues Guidance for Conducting Clinical Trials

CLIA Waiver Final Guidance Documents

FDA Releases Temporary New Guidance on Hand Sanitizer

The World Health Organization just announced...

Ethylene Oxide Sterilization facility updates

FDA releases new guidance..

FDA published a revision to MAPP

Public meeting announcement..

Are you worried about the US Hemp rules??

Congratulations Compliance Insight!!

Data Integrity and GMP's

The FDA is sending out a warning about Biotin

Did you know this about hemp??

CBD and dinner? You bet!